[HTML] mdpi.com

[HTML][HTML] Single center experience using monoclonal COVID-19 antibodies in the management of immunocompromised patients with COVID-19

D Klank, B Claus, R Bergner, P Paschka - Microorganisms, 2022 - mdpi.com
The medical care of immunocompromised patients with COVID-19 infection causes major
hurdles in the management of these patients in clinical practice. However, poor responses to …
被引用次数：1 相关文章
[PDF] researchgate.net

[PDF][PDF] Single Center Experience Using Monoclonal COVID-19 Antibodies in the Management of Immunocompromised Patients with COVID-19. Microorganisms 2022 …

D Klank, B Claus, R Bergner, P Paschka - 2022 - researchgate.net
The medical care of immunocompromised patients with COVID-19 infection causes major
hurdles in the management of these patients in clinical practice. However, poor responses to …
[HTML] nih.gov

[HTML][HTML] Single Center Experience Using Monoclonal COVID-19 Antibodies in the Management of Immunocompromised Patients with COVID-19

D Klank, B Claus, R Bergner, P Paschka - Microorganisms, 2022 - ncbi.nlm.nih.gov
The medical care of immunocompromised patients with COVID-19 infection causes major
hurdles in the management of these patients in clinical practice. However, poor responses to …

Single Center Experience Using Monoclonal COVID-19 Antibodies in the Management of Immunocompromised Patients with COVID-19.

D Klank, B Claus, R Bergner, P Paschka - Microorganisms, 2022 - search.ebscohost.com
The medical care of immunocompromised patients with COVID-19 infection causes major
hurdles in the management of these patients in clinical practice. However, poor responses to …

Single Center Experience Using Monoclonal COVID-19 Antibodies in the Management of Immunocompromised Patients with COVID-19

D Klank, B Claus, R Bergner, P Paschka - Microorganisms, 2022 - search.proquest.com
The medical care of immunocompromised patients with COVID-19 infection causes major
hurdles in the management of these patients in clinical practice. However, poor responses to …

Single Center Experience Using Monoclonal COVID-19 Antibodies in the Management of Immunocompromised Patients with COVID-19

D Klank, B Claus, R Bergner, P Paschka - Microorganisms, 2022 - europepmc.org
The medical care of immunocompromised patients with COVID-19 infection causes major
hurdles in the management of these patients in clinical practice. However, poor responses to …

Single Center Experience Using Monoclonal COVID-19 Antibodies in the Management of Immunocompromised Patients with COVID-19

D Klank, B Claus, R Bergner… - Microorganisms, 2022 - pubmed.ncbi.nlm.nih.gov
The medical care of immunocompromised patients with COVID-19 infection causes major
hurdles in the management of these patients in clinical practice. However, poor responses to …

Single center experience using monoclonal COVID-19 antibodies in the management of immunocompromised patients with COVID-19.

D Klank, B Claus, R Bergner, P Paschka - 2022 - cabidigitallibrary.org
The medical care of immunocompromised patients with COVID-19 infection causes major
hurdles in the management of these patients in clinical practice. However, poor responses to …
[PDF] semanticscholar.org

[PDF][PDF] Single Center Experience Using Monoclonal COVID-19 Antibodies in the Management of Immunocompromised Patients with COVID-19. Microorganisms 2022 …

D Klank, B Claus, R Bergner, P Paschka - 2022 - pdfs.semanticscholar.org
The medical care of immunocompromised patients with COVID-19 infection causes major
hurdles in the management of these patients in clinical practice. However, poor responses to …
[PDF] academia.edu

[PDF][PDF] Single Center Experience Using Monoclonal COVID-19 Antibodies in the Management of Immunocompromised Patients with COVID-19. Microorganisms 2022 …

D Klank, B Claus, R Bergner, P Paschka - 2022 - academia.edu
The medical care of immunocompromised patients with COVID-19 infection causes major
hurdles in the management of these patients in clinical practice. However, poor responses to …